Jason Carr

About the Author Jason Carr


H.C. Wainwright Sticks to Its Buy Rating for KemPharm (KMPH)

In a report released today, Oren Livnat from H.C.

Biospecifics Technologies (BSTC) Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C.

H.C. Wainwright Sticks to Their Buy Rating for Corvis Gold (CORVF)

In a report released today, Heiko Ihle from H.C.

QAD (QADA) Receives a Buy from B.Riley FBR

B.Riley FBR analyst Zach Cummins maintained a Buy rating on QAD (QADA) today and set a price target of $48.

JonesTrading Reiterates a Buy Rating on Surface Oncology (SURF)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Surface Oncology (SURF), with a price target of $12.00.

Crispr Therapeutics AG (CRSP) Gets a Buy Rating from Wells Fargo

Wells Fargo analyst Jim Birchenough maintained a Buy rating on Crispr Therapeutics AG (CRSP) today. The company’s shares closed last Monday at $68.

Mizuho Securities Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Akebia Therapeutics (AKBA), with a price target of …

EuroDry (EDRY) Gets a Buy Rating from Maxim Group

Maxim Group analyst Tate Sullivan maintained a Buy rating on EuroDry (EDRY) yesterday and set a price target of $9.00.

Piper Jaffray Sticks to Its Buy Rating for Mammoth Energy Services (TUSK)

Piper Jaffray analyst John Daniel maintained a Buy rating on Mammoth Energy Services (TUSK) today and set a price target of $3.00.

Talend SA (TLND) Receives a Buy from Needham

In a report released yesterday, Jack Andrews from Needham reiterated a Buy rating on Talend SA (TLND), with a price target of $65.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts